Healthcare VC building biotech companies, organic chemist, fisherman, runner, fan of all things Boston, faithful Michigan alum
Dec 14, 2022 • 14 tweets • 3 min read
Given yesterdays news of $AMGN buying $HZN for $28B I’ve been asked to give color to the Tepezza history by a few people in a Tweet Thread. So here it goes. It’s my fist so be kind.
Researchers Terry Smith and Ray Douglas at the time of University of Michigan (#GoBlue) had been studying the role of IGF-1R in a condition affecting a subset of Graves’ patients called Graves Orbitopathy or Thyroid Eye Disease (TED)